CYP2D6*10/*10基因型可显著增加坦索罗辛的暴露量。 - Suppr

Suppr

超能文献

Tamsulosin exposure is significantly increased by the CYP2D610/10 genotype.

作者信息

Choi Chang-Ik, Bae Jung-Woo, Jang Choon-Gon, Lee Seok-Yong

机构信息

School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea.

出版信息

J Clin Pharmacol. 2012 Dec;52(12):1934-8. doi: 10.1177/0091270011432168. Epub 2012 Jan 12.

DOI:10.1177/0091270011432168

PMID:22245658

Abstract

摘要

相似文献

Tamsulosin exposure is significantly increased by the CYP2D6*10/*10 genotype.CYP2D6*10/*10基因型可显著增加坦索罗辛的暴露量。

J Clin Pharmacol. 2012 Dec;52(12):1934-8. doi: 10.1177/0091270011432168. Epub 2012 Jan 12.

Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.CYP2D6和CYP3A5基因多态性对坦索罗辛在人体内稳态药代动力学及血流动力学效应的影响。

Eur J Clin Pharmacol. 2018 Oct;74(10):1281-1289. doi: 10.1007/s00228-018-2501-x. Epub 2018 Jun 13.

Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes.地尔硫䓬（CYP3A4 的中度抑制剂）对不同 CYP2D6 基因型人群中坦索罗辛药代动力学的影响。

Arch Pharm Res. 2018 May;41(5):564-570. doi: 10.1007/s12272-018-1030-6. Epub 2018 May 4.

Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele.基于生理学的坦索罗辛药代动力学（PBPK）模型与 CYP2D6*10 等位基因相关。

Arch Pharm Res. 2021 Nov;44(11):1037-1049. doi: 10.1007/s12272-021-01357-z. Epub 2021 Nov 9.

Impact of four loci on serum tamsulosin hydrochloride concentration.四个基因座对血清坦索罗辛盐酸盐浓度的影响。

J Hum Genet. 2013 Jan;58(1):21-6. doi: 10.1038/jhg.2012.126. Epub 2012 Nov 15.

Tamsulosin for ureteral stones--use in a pediatric population?坦索罗辛用于输尿管结石——在儿科人群中的应用？

Urol Nurs. 2012 Mar-Apr;32(2):88-92.

Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity?坦索罗辛在人前列腺中的游离药物分数高于血浆：尿选择性的基础？

Br J Clin Pharmacol. 2011 Aug;72(2):218-25. doi: 10.1111/j.1365-2125.2010.03870.x.

CYP2D6 genotype and phenotype relationship in South Indians.南印度人群中CYP2D6基因与表型的关系

J Postgrad Med. 2006 Oct-Dec;52(4):245.

Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.坦索罗辛和特拉唑嗪药代动力学的放射受体分析

Br J Clin Pharmacol. 1998 Jan;45(1):49-55. doi: 10.1046/j.1365-2125.1998.00636.x.

Pharmacokinetics, safety, and tolerability of atomoxetine and effect of CYP2D6*10/*10 genotype in healthy Japanese men.在健康的日本男性中，阿托西汀的药代动力学、安全性和耐受性，以及 CYP2D6*10/*10 基因型的影响。

J Clin Pharmacol. 2012 Mar;52(3):388-403. doi: 10.1177/0091270011398657. Epub 2011 May 4.

引用本文的文献

Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management.西洛多辛暴露与疗效的基因调控：CYP3A4、CYP3A5和UGT2B7基因多态性在良性前列腺增生治疗中的作用

J Pers Med. 2025 Aug 18;15(8):386. doi: 10.3390/jpm15080386.

Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms.基于生理的药代动力学模型揭示文拉法辛的药物-基因相互作用：基于 CYP2D6 和 CYP2C19 多态性的活性评分依赖性代谢。

Pharm Res. 2024 Apr;41(4):731-749. doi: 10.1007/s11095-024-03680-8. Epub 2024 Mar 5.

Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone.CYP2D6 和 CYP2C19 基因多态性及吸烟对托哌酮药代动力学的影响。

Arch Pharm Res. 2023 Aug;46(8):713-721. doi: 10.1007/s12272-023-01462-1. Epub 2023 Sep 20.

Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes.基于生理学的药代动力学模型预测不同 CYP2D6 基因型中美托洛尔的药代动力学。

Arch Pharm Res. 2022 Jun;45(6):433-445. doi: 10.1007/s12272-022-01394-2. Epub 2022 Jun 28.

Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele.基于生理学的坦索罗辛药代动力学（PBPK）模型与 CYP2D6*10 等位基因相关。

Arch Pharm Res. 2021 Nov;44(11):1037-1049. doi: 10.1007/s12272-021-01357-z. Epub 2021 Nov 9.

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin.细胞色素P450和转运体基因多态性对度他雄胺和坦索罗辛生物利用度及安全性的影响。

Front Pharmacol. 2021 Oct 7;12:718281. doi: 10.3389/fphar.2021.718281. eCollection 2021.

Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects.韩国健康受试者中唑吡坦的血浆暴露量与CYP2D6基因分型的关系。

Arch Pharm Res. 2020 Sep;43(9):976-981. doi: 10.1007/s12272-020-01250-1. Epub 2020 Jul 13.

Challenges to assess substrate-dependent allelic effects in CYP450 enzymes and the potential clinical implications.评估 CYP450 酶中底物依赖性等位基因效应的挑战及潜在临床意义。

Pharmacogenomics J. 2019 Dec;19(6):501-515. doi: 10.1038/s41397-019-0105-1. Epub 2019 Oct 15.

Eur J Clin Pharmacol. 2018 Oct;74(10):1281-1289. doi: 10.1007/s00228-018-2501-x. Epub 2018 Jun 13.

Human hepatocytes and cytochrome P450-selective inhibitors predict variability in human drug exposure more accurately than human recombinant P450s.人源肝细胞和细胞色素 P450 选择性抑制剂比人源重组 P450 更能准确预测人体药物暴露的个体差异。

Br J Pharmacol. 2018 Jun;175(11):2116-2129. doi: 10.1111/bph.14203. Epub 2018 Apr 19.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验